Search research articles
Contact Us
Filters
Showing results (61-70 of 133) with videos related to
Page
of 14
Sort By:
Leukemia & Lymphoma
|
December 8, 2022
A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies
Bilal Tariq, Ying C Ou, Jennifer C Stern, et al.
Internal Medicine Journal
|
March 21, 2025
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report
Arina Martynchyk, Cameron Wellard, Eliza Chung, et al.
Thrombosis Research
|
November 27, 2018
Bleeding and thrombotic events occur early in children on durable ventricular assist devices
Joanna Y Huang, Vera Ignjatovic, Bennett J Sheridan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2009
Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma
Mark A Dawson, Stephen S Opat, Yamna Taouk, et al.
Acta Haematologica
|
January 30, 2024
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Richard Blennerhassett, Nada Hamad, Lisa Grech, et al.
BMC Infectious Diseases
|
January 21, 2022
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
Amy Body, Elizabeth Ahern, Luxi Lal, et al.
Scientific Reports
|
September 21, 2019
Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma
Sumita Ratnasingam, Joshua Casan, Jake Shortt, et al.
Internal Medicine Journal
|
June 17, 2024
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Masa Lasica, Mary A Anderson, Alex Boussioutas, et al.
Blood Advances
|
April 7, 2022
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
Tycel Phillips, Henry Chan, Constantine S Tam, et al.
Blood Advances
|
January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
Sumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 133) with videos related to
Sort By:
Page
of 14
Leukemia & Lymphoma
|
December 8, 2022
A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies
Bilal Tariq, Ying C Ou, Jennifer C Stern, et al.
Internal Medicine Journal
|
March 21, 2025
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report
Arina Martynchyk, Cameron Wellard, Eliza Chung, et al.
Thrombosis Research
|
November 27, 2018
Bleeding and thrombotic events occur early in children on durable ventricular assist devices
Joanna Y Huang, Vera Ignjatovic, Bennett J Sheridan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2009
Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma
Mark A Dawson, Stephen S Opat, Yamna Taouk, et al.
Acta Haematologica
|
January 30, 2024
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Richard Blennerhassett, Nada Hamad, Lisa Grech, et al.
BMC Infectious Diseases
|
January 21, 2022
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
Amy Body, Elizabeth Ahern, Luxi Lal, et al.
Scientific Reports
|
September 21, 2019
Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma
Sumita Ratnasingam, Joshua Casan, Jake Shortt, et al.
Internal Medicine Journal
|
June 17, 2024
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Masa Lasica, Mary A Anderson, Alex Boussioutas, et al.
Blood Advances
|
April 7, 2022
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
Tycel Phillips, Henry Chan, Constantine S Tam, et al.
Blood Advances
|
January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
Sumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
Page
of 14